Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 83501-83550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05308641
Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients With Chronic Low Back Pain
NAActive, not recruiting
400 participants
Started: Sep 18, 2022 · Completed: Dec 7, 2025
1 condition1 sponsor1 location
NCT05517291
DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease
NARecruiting
200 participants
Started: Sep 18, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05741775
Physiotherapy Intervention for Migraine Symptoms
PHASE3Recruiting
87 participants
Started: Sep 18, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05547698
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
NARecruiting
228 participants
Started: Sep 17, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor5 locations
NCT05509257
Naltrexone Neuroimaging in Teens with Eating Disorders
EARLY_PHASE1Recruiting
60 participants
Started: Sep 17, 2022 · Completed: Jun 30, 2027
5 conditions3 sponsors1 location
NCT05766046
Lung Cancer Prevention Screening Programme in Italy
NARecruiting
7,324 participants
Started: Sep 17, 2022 · Completed: Sep 30, 2026
3 conditions18 sponsors1 location
NCT05461170
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
PHASE2Active, not recruiting
95 participants
Started: Sep 17, 2022 · Completed: Aug 31, 2029
1 condition1 sponsor20 locations
NCT05455515
The GISE (Società Italiana di Cardiologia Interventistica) - ShockCalcium Registry
N/ARecruiting
2,000 participants
Started: Sep 17, 2022 · Completed: Aug 1, 2026
1 condition4 sponsors1 location
NCT05607199
A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
PHASE1Recruiting
80 participants
Started: Sep 16, 2022 · Completed: Oct 16, 2026
4 conditions1 sponsor5 locations
NCT05878028
L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC
PHASE2Recruiting
33 participants
Started: Sep 16, 2022 · Completed: Sep 15, 2025
1 condition1 sponsor1 location
NCT05447377
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants
PHASE3Recruiting
2,216 participants
Started: Sep 16, 2022 · Completed: Jan 30, 2024
1 condition1 sponsor2 locations
NCT05540327
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
PHASE2Active, not recruiting
379 participants
Started: Sep 16, 2022 · Completed: Aug 12, 2028
1 condition1 sponsor122 locations
NCT05548114
Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction
NAActive, not recruiting
74 participants
Started: Sep 16, 2022 · Completed: Dec 31, 2025
1 condition6 sponsors1 location
NCT06545877
REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)
N/ARecruiting
500 participants
Started: Sep 16, 2022 · Completed: Jun 22, 2029
1 condition1 sponsor1 location
NCT05020704
EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction
PHASE3Active, not recruiting
100 participants
Started: Sep 16, 2022 · Completed: Jun 12, 2024
1 condition2 sponsors3 locations
NCT05442125
First Live Birth Rate With eSET After Preimplantation Methylome Screening (PIMS) Versus Conventional In-vitro Fertilization
NARecruiting
1,146 participants
Started: Sep 16, 2022 · Completed: May 31, 2025
2 conditions27 sponsors28 locations
NCT05206955
Study of Tadalafil Vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
PHASE3Recruiting
80 participants
Started: Sep 16, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT04681339
Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
N/ARecruiting
200 participants
Started: Sep 16, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05298748
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
NARecruiting
34 participants
Started: Sep 16, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT05766410
A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC
PHASE2Recruiting
60 participants
Started: Sep 16, 2022 · Completed: Sep 30, 2026
3 conditions1 sponsor2 locations
NCT05512819
A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan
PHASE3Active, not recruiting
401 participants
Started: Sep 16, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor11 locations
NCT05345587
Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy
NARecruiting
196 participants
Started: Sep 16, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor6 locations
NCT05219331
Hydrocephalus Treatment on Persistent Disorder of Consciousness
NARecruiting
20 participants
Started: Sep 16, 2022 · Completed: Apr 1, 2025
1 condition1 sponsor2 locations
NCT05550090
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
N/ARecruiting
40 participants
Started: Sep 16, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06078605
Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients
NARecruiting
80 participants
Started: Sep 16, 2022 · Completed: Jun 30, 2024
1 condition2 sponsors1 location
NCT05867173
Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
NARecruiting
200 participants
Started: Sep 16, 2022 · Completed: Mar 31, 2027
1 condition3 sponsors2 locations
NCT05555264
Enhancing Internet-delivered Cognitive Behaviour Therapy for Alcohol Misuse
NAActive, not recruiting
205 participants
Started: Sep 16, 2022 · Completed: Mar 31, 2025
1 condition3 sponsors1 location
NCT06294275
A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects
PHASE1Active, not recruiting
68 participants
Started: Sep 16, 2022 · Completed: Apr 6, 2024
1 condition1 sponsor1 location
NCT04264065
Albumin and Prognosis of Severely Patients Burns
N/ARecruiting
200 participants
Started: Sep 16, 2022 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05534607
Natives Engaged in Alzheimers Research - 'Ike Kupuna
NARecruiting
192 participants
Started: Sep 15, 2022 · Completed: Apr 30, 2027
2 conditions1 sponsor3 locations
NCT05879783
Optical Biopsy for Peritoneal Nodules in Colorectal Patients
NARecruiting
278 participants
Started: Sep 15, 2022 · Completed: Dec 15, 2027
1 condition1 sponsor1 location
NCT05466890
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
PHASE2Active, not recruiting
16 participants
Started: Sep 15, 2022 · Completed: Mar 31, 2025
4 conditions1 sponsor14 locations
NCT05763602
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
PHASE4Recruiting
2,000 participants
Started: Sep 15, 2022 · Completed: Feb 15, 2026
1 condition8 sponsors6 locations
NCT06617650
GenerationGemelli: Longitudinal Study for the Evaluation of the Maternal Exposome on the Health of the Newborn and Child
N/ARecruiting
140 participants
Started: Sep 15, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05546307
Interest of Prior Relaxation on the Recordings of the SomatoSensory Evoked Potentials
NARecruiting
242 participants
Started: Sep 15, 2022 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT05501925
GlideSheath Slender® Versus Conventional 6 French Arterial Sheath: Impact on the Distal Radial Artery Occlusion (SMART)
NARecruiting
600 participants
Started: Sep 15, 2022 · Completed: Feb 28, 2024
2 conditions1 sponsor1 location
NCT05520619
Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)
PHASE2Active, not recruiting
114 participants
Started: Sep 15, 2022 · Completed: Jul 31, 2026
2 conditions4 sponsors1 location
NCT05652192
SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
PHASE2Recruiting
37 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05539794
Exercise and Lifestyle in Adolescent Cancer (HEALTHYADOL)
NARecruiting
136 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05336968
Triamcinolone Ketorolac (TriKe) Knee Trial
PHASE4Recruiting
150 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03886025
Combined Anodal Transcranial Direct Current Stimulation (tDCS) and Cognitive Training and Decision-making
NARecruiting
60 participants
Started: Sep 15, 2022 · Completed: Dec 30, 2026
2 conditions2 sponsors1 location
NCT04428658
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
NARecruiting
82 participants
Started: Sep 15, 2022 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05304442
IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
PHASE3Recruiting
40 participants
Started: Sep 15, 2022 · Completed: Apr 30, 2025
2 conditions2 sponsors1 location
NCT05737381
Quality of Human Embryos in IVF, Culturing in Differentiated Oxygen
NARecruiting
350 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT04166656
Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.
PHASE3Recruiting
84 participants
Started: Sep 15, 2022 · Completed: Oct 31, 2028
1 condition6 sponsors1 location
NCT05758961
Le French Gut: Characterization of Gut Microbiota Profiles in France
N/ARecruiting
100,000 participants
Started: Sep 15, 2022 · Completed: Sep 15, 2042
1 condition2 sponsors1 location
NCT05201144
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
PHASE2Recruiting
40 participants
Started: Sep 15, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT05409872
Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids
NARecruiting
108 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05278494
Dextromethorphan for Treatment of Postoperative Pain
NARecruiting
160 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05454852
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia
N/AActive, not recruiting
771 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors2 locations